Board Certified Neurosurgeon Joins DHR Health Neuroscience Institute  

Translate to Spanish or other 102 languages!

Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source:  googlemaps
Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source: googlemaps

Mega Doctor News

- Advertisement -

Edinburg, TX – The DHR Health Neuroscience Institute is pleased to welcome Inad B. Atassi, M.D, F.A.C.S., to the team. Utilizing the most advanced surgical techniques to provide comprehensive neurological care to patients, Dr. Atassi specializes in the treatment of brain tumors, spinal cord tumors, stroke and traumatic head & spine injuries.

Dr. Atassi is Board Certified in Neurosurgery and brings more than 35 years of experience in the field to patients of the Rio Grande Valley. He received his Doctor of Medicine at Damascus University in Damascus, Syria. He completed his General Surgery residency at Henry Ford Hospital in Detroit, Michigan and continued his Neurosurgery residency training at the University of Kansas Medical Center in Kansas City, Kansas.

Dr. Atassi has been in private practice, as well as worked in clinics and hospitals around the world providing neurologic care to adult and pediatric patients before bringing his talents to South Texas in 2020.He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, American College of Surgeons, North Carolina Medical Society, Cumberland County Medical Society, and North American Spine Society.

- Advertisement -

To schedule an appointment with Dr. Atassi, please call (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

STHS Heart Ranks Among Nation’s Top Hospitals for Heart Attack Care

Every year, more than 800,000 people in the United States suffer a heart attack, according to the Centers for Disease Control and Prevention, an event that occurs approximately every 40 seconds.
- Advertisement -